Open AccessMisa, Post COVID complication
Author(s) -
C. M Wazeem,
Kirangkulirankal,
Vimalkumar Velayudhan,
- Merlin,
Mary Ann
Publication year - 2021
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v5ns2.5863
Subject(s) - myalgia , medicine , complication , sepsis , septic shock , covid-19 , immunology , pediatrics , disease , infectious disease (medical specialty)
Multisystem inflammatory syndrome in adults (MIS-A) is an rare and underrecognised postinfectious manifestation that occurs 4–6 weeks after COVID-19 infection. Patients affected tend to be young or middle-aged, from ethnic minority backgrounds and previously healthy. The patient suffer from high fever and myalgia, and there is myriad of extrapulmonary symptoms and signs, including cardiac, gastrointestinal, neurological and dermatological involvement. Cardiovascular shock and markedly raised inflammatory markers are prominent features, while significant hypoxia is uncommon. Patients respond well to corticosteroid therapy, but failure of clinicians to recognise this recently identified phenomenon, which can mimic common conditions including sepsis, could delay diagnosis and treatment. Here we present a case of MIS-A in an adult men, with severe illness and positive test result for SARS-CoV-2 infection (PC, antigen, or antibody).There was severe extrapulmonary organ system dysfunction;There was markedly elevated acute inflammatory markers; .there was no any respiratory illness.